TG Therapeutics News, TG Therapeutics Quote, TGTX Quote

TG Therapeutics (NQ:TGTX) Delayed: 54.87 -0.06 (0.11%)

Prev. Close

$54.93

Today 6M 1Y 5Y

Open

$54.25

52 Wk High

$14.87

52 Wk Low

$4.90

Day High

$55.78

Day Low

$53.54

P/E

N/A

EPS

$-0.67

Volume

3,408,548

Friends, Peers and Foes (?): DTIL, BMY, MRK, NVS QNTM (more...)

ALERTS | RSS

Jul 7, 2026 05:16 AM TG Therapeutics (TGTX) PT Raised to $20 at BofA Securities
Jul 6, 2026 07:31 AM TG Therapeutics starts Phase 2 trial of Briumvi for schizophrenia
Jul 6, 2026 07:30 AM TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
Jun 24, 2026 08:30 AM The Quest to Repair What Multiple Sclerosis Takes Away
Jun 15, 2026 05:03 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Lonial Sagar
Jun 15, 2026 05:03 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: HUME DANIEL
Jun 15, 2026 05:02 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Hoberman Kenneth
Jun 15, 2026 05:01 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Echelard Yann
Jun 15, 2026 05:01 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Charney Laurence N
Jun 12, 2026 04:33 PM Form 8-K TG THERAPEUTICS, INC. For: Jun 11

Entities mentioned with TGTX

View All Entities